Pages
The makers of Tide rinse away the boss: P&G CEO steps down
David Gura May 24, 2013
After a disappointing first quarter, CEO Bob McDonald says he will leave Procter & Gamble at the end of next month.
Americans are not happy with their Internet service providers
Ben Johnson May 22, 2013
The latest American Customer Satisfaction Index is out, and one industry in an unfortunate spot when it comes to customer satisfaction: Internet service providers.
What will it take to make tornado prediction better?
Shannon Mullen May 21, 2013
Prediction for tornadoes like the one in Moore, Okla., has gotten pretty good. Building thousands of new radar stations would make it better.
This burger brought to you by a test tube
Stephen Beard May 21, 2013
Dutch scientists will shortly unveil a burger that uses meat grown at great expense in a laboratory. Growing meat is more efficient in the long-term, but people may not take to it.
What's behind the uptick in consumer spending?
Stacey Vanek Smith May 17, 2013
Retail sales rose a tenth of a percent in April. Why are people spending more and are they going back into credit card debit over these purchases?
Will dollars follow the stem cell breakthrough?
Dan Gorenstein May 16, 2013
Researchers have figured out how to clone human embryonic stems cells, which can be used to develop tissue for many uses. Will investors jump in?
Orbiting Kepler telescope may be unable to gather more data
Sally Herships May 16, 2013
Space scientists say Kepler has already found enough potential and confirmed planets to keep them busy for years.
Retail makes modest gains
David Brancaccio May 15, 2013
A look at how new retail figures impact the economy.
Retailers around the world react to Bangladesh fire
Krissy Clark May 15, 2013
After last month's collapse at a garment factory, retailers around the world are responding in different ways.
The cost of Angelina Jolie's cancer testing? More than $4,000
Stacey Vanek Smith May 15, 2013
Angelina Jolie's double mastectomy is likely to boost demand for a medical test that determines the probability of breast cancer. That test is currently available from just one company, Myriad Genetics, which charges more than $4,000.
